Bioprocess– tag –
-
Dynamic Perfusion Culture Revolutionizes Monoclonal Antibody Manufacturing: Maximizing Product Quality and Yield, Driving Continuous Biomanufacturing
Bioprocess Online USA Overview While fed-batch remains standard for mAb production, dynamic perfusion culture offers compelling opportunities to boost product quality, yield, and facility utilization by optimizing cell growth and metabol... -
AI and Digital Twins Accelerate Cultivated Meat Commercialization: Bioprocess Optimization Drives Cost Reduction and Productivity
Food Engineering USA Overview A hybrid model digital twin strategy, combining AI with mechanistic bioprocess modeling, is emerging as an indispensable tool for commercially scaling cultivated meat production. These virtual models optimiz... -
CDMOs Overcome Multispecific Manufacturing Challenges with Continuous Bioprocessing and Catalent’s GPEx® Lightning Platform
BioSpace Unknown Overview Contract Development and Manufacturing Organizations (CDMOs) confront complex challenges in cell line development, analytical characterization, and downstream purification for multispecific molecules. To overcom... -
Modular Bioprocessing Future: Digital Twins and AI Revolutionize Manufacturing, Drastically Reducing Downtime
Industry Publication Unknown Overview Modular bioprocessing is evolving with digital control and AI, significantly boosting efficiency and reliability in biopharmaceutical manufacturing. Digital twin technology is key, enabling predictiv... -
Continuous Upstream Bioprocessing Gains Traction, WuXi Biologics Pioneers Fully Automated Perfusion Platform for Enhanced Productivity
Pharma Manufacturing USA Overview Continuous upstream bioprocessing, especially perfusion culture, is significantly enhancing productivity and consistency in biomanufacturing. CDMOs are increasing investments in continuous bioprocessing ... -
The Bioreactor Scaling Conundrum: Navigating Flexibility, Yield, and Design Trade-offs in Biopharmaceutical Manufacturing
Nature Partnerships International Overview Scaling bioprocess production in bioreactors presents a formidable challenge, characterized by inherent trade-offs between flexibility, cell yield, and process design. Bioreactor specifications ... -
Small-Scale Bioreactors Market Sees Robust Growth Driven by Innovation; Culture Biosciences and Cytiva Bioscience Partnership Advances Automation
openPR.com International Overview This article provides an overview of a market research report introduced by openPR.com, highlighting significant growth in the small-scale bioreactors market, driven by innovations in bioprocessing effic... -
Retinal Diseases Emerge as Key Proving Ground for Next-Gen iPSC Regenerative Therapies, BioProcess International Reports
BioProcess International USA Overview BioProcess International reports that iPSC-derived regenerative therapies are increasingly seen as the primary proving ground for next-generation treatments in retinal diseases. iPSCs enable scalable... -
Lonza Unveils Rapid Custom Media Prototyping Service (RaMP) to Drastically Accelerate Early Bioprocess Development Timelines
Outsourced Pharma Global Overview Lonza has launched its Rapid Media Prototyping Service (RaMP) to significantly shorten early bioprocess development timelines for biopharmaceutical companies. This service provides custom liquid and powd... -
Integration of Digital Twins, AI, PAT, and IoT Revolutionizes Single-Use Mixing Solutions in Bioprocess Engineering for Enhanced Robustness
Facebook Global Overview In bioprocess engineering, the selection of single-use mixing solutions is significantly advanced by integrating digital twin technology, AI/machine learning (ML), Process Analytical Technology (PAT), IoT, and so...
